Drug
LEO 90100 clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 4
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Betamethasone dipropionate, calcipotriol drug combination (2) · Clobetasol (1) · Fluocinolone Acetonide (1) · Betamethasone dipropionate (1) · Betamethasone (1) · Mometasone Furoate (1) · Hydrocortisone butyrate (1)
Studies
Open first, then newest update. How each study uses LEO 90100 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02310646Written as LEO 90100 Aerosol Foam
- A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT02518048Written as LEO 90100 Aerosol foam
- LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02132936Written as LEO 90100 aerosol foam
- Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT03806790Written as LEO 90100 foam
- A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT01347255Written as LEO90100 cutaneous spray, ointment
- Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese SubjectsCompletedPhase 1LEO PharmaNCT03442244Written as LEO 90100 foam
- A Vasoconstriction Study With LEO 90100CompletedPhase 1LEO PharmaNCT01946386Written as LEO 90100 Aerosol, foam
- Dermatopharmacokinetic Trial of LEO 90100 FoamCompletedPhase 1LEO PharmaNCT03476746Written as LEO 90100 foam
- LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02899962Written as LEO 90100 aerosol foam
- Vasoconstriction Trial With LEO 90100 Aerosol FoamCompletedPhase 1LEO PharmaNCT02973776Written as LEO 90100 aerosol foam